Cargando…
Revisiting PPARγ as a new friend of GPR120 in the treatment of metabolic disorders
G Protein-coupled receptor 120 (GPR120; fatty acid receptor 4, FFAR4) and PPARγ agonists both lead to anti-inflammatory and insulin sensitizing effects despite signalling through distinct pathways. We recently reported the overarching idea that these two pathways are interactive. Specifically, treat...
Autores principales: | Paschoal, Vivian A., Oh, Da Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595585/ https://www.ncbi.nlm.nih.gov/pubmed/33108252 http://dx.doi.org/10.1080/21623945.2020.1838186 |
Ejemplares similares
-
Revisiting PPARγ as a target for the treatment of metabolic disorders
por: Choi, Sun-Sil, et al.
Publicado: (2014) -
PPARγ in Bacterial Infections: A Friend or Foe?
por: Reddy, Aravind T., et al.
Publicado: (2016) -
The Role of GPR120 Receptor in Essential Fatty Acids Metabolism in Schizophrenia
por: Rog, Joanna, et al.
Publicado: (2020) -
The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders
por: Porcuna, Jesús, et al.
Publicado: (2021) -
Regulation of Energy Homeostasis via GPR120
por: Ichimura, Atsuhiko, et al.
Publicado: (2014)